Cardiome Pharma Corp. (CRME) SEC Filings - Page 1

SEC Filings for Cardiome Pharma Corp. (CRME) 
$ 2.41   -0.14 (-5.49%) Volume: 126.05 k 4:00 PM EST Feb 10, 2012
Filing Type:
Form TypeForm DescriptionPagesDateView
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act3111/04/2011
   
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act511/04/2011
   
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act211/03/2011
   
SC 13GStatement of beneficial ownership of common stock by certain persons1010/13/2011
   
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act3008/09/2011
   
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act407/26/2011
   
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act207/26/2011
   
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act306/21/2011
   
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act2505/16/2011
   
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act605/16/2011
   
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act4205/11/2011
   
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act603/16/2011
   
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act403/16/2011
   
40-FRegistration of a class of securities of certain Canadian issuers under Section 12(b) of the 1934 Act12703/11/2011
   
6-KReport of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act503/10/2011
   
<<
First
<
Prev
123456789101112131415